Skip to main content
. 2020 Aug 19;2020:8813535. doi: 10.1155/2020/8813535

Table 1.

Baseline clinical characteristics of the study participants.

Characteristic Patients with brain tumors (n = 55) Healthy volunteers (n = 24) P
Age (years) 47.42 ± 15.72 40.63 ± 14.42 0.074
Female 31 (56.4%) 13 (51.2%) 0.857
Tumor location
 Frontal lobe 15 (27.3%) N/A N/A
 Temporal lobe 14 (25.5%) N/A N/A
 Occipital lobe 6 (10.9%) N/A N/A
 Parietal lobe 3 (5.5%) N/A N/A
 Sella region 6 (10.9%) N/A N/A
 Cerebellum 4 (7.3%) N/A N/A
 Brain stem 5 (9.1%) N/A N/A
 Basal ganglia 2 (3.6%) N/A N/A
Tumor pathology
 Glioma 22 (40.0%) N/A N/A
 Meningioma 12 (21.8%) N/A N/A
 Neurilemmoma 7 (12.7%) N/A N/A
 Hypophysoma 4 (7.3%) N/A N/A
 Hemangioma 4 (7.3%) N/A N/A
 Germinoma 2 (3.6%) N/A N/A
 Craniopharyngioma 2 (3.6%) N/A N/A
 Chordoma 1 (1.8%) N/A N/A
 Cholesteatoma 1 (1.8%) N/A N/A

Data are presented as mean ± standard deviation or n (%). N/A: not applicable.